News – Page 1101 – Endpoints News

Pining for a megadeal, an analyst kicks the tires for another Gilead M&A test drive

8 years ago

AI drug discovery success inspires a machine-learning startup at the Mayo Clinic

8 years ago

White House doubles down on call to fund FDA entirely with industry fees

8 years ago

J&J gets a quick FDA OK for its blockbuster psoriasis contender guselkumab

8 years ago

Merck KGaA life sciences reorg will claim 200 jobs; Tesaro shares sink on new report discounting buyout talk

8 years ago

GlaxoSmithKline woos Pfizer medicinal sciences chief Tony Wood to high-level R&D job

8 years ago

Ex-GSK CEO Andrew Witty goes biotech, taking a board seat at G1

8 years ago

Facing a critical August deadline, House passes bill to reauthorize FDA user fee programs

8 years ago

Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva

8 years ago

FDA advisers back Novartis’ game-changing personalized CAR-T for cancer, approval in sight

8 years ago

Erytech collaborates on rare disease drug; Enterome creates diagnostics venture with Nestlé

8 years ago

Pfizer’s data mining hits pay dirt as FDA panel backs a comeback for Mylotarg

8 years ago

D-day: Novartis arrives at a crossroad in the blockbuster race to win the first FDA OK for CAR-T

8 years ago

Ocular Therapeutix's last-minute gambit fails to salvage its second FDA application, shares plunge

8 years ago

The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise

8 years ago

Big Pharma VCs jump in to back a $63M mission to tackle a genetic driver of Alzheimer’s

8 years ago

The business model of Endpoints News — and why you should subscribe

8 years ago

Neothetics sheds staff, looks for survival strategy in wake of trial failure; GSK walks away from OncoMed pact

8 years ago

BioMarin lays out its PhIII strategy for its closely-watched gene therapy for hemophilia A

8 years ago

Sanofi finally manages to close on a buyout – but it’s not a game changer

8 years ago

Arena takes a big step down the comeback trail with PhII success, shares rocket up

8 years ago

FDA orders a rare retreat on Amicus’ migalastat, dropping PhIII demand and signaling a major shift for drug ...

8 years ago

After raising $100M, Google-backed Evelo looks to blaze a new trail with monoclonal microbials

8 years ago

Pioneering gene therapy patients stay on track, boosting Spark’s hemophilia B program

8 years ago

First page Previous page 1098 1099 110011011102 1103 1104 Next page Last page